GJGun-Jae Jeong

Gun-Jae Jeong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gun-Jae Jeong has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Biaggio Uricoli

    Coulter Department of Biomedical Engineering, Georgia Institute of Technology & Emory University School of Medicine, Atlanta, USA

    1 shared publication
  • Hyocheol Jung

    Center for Specialty Chemicals, Division of Specialty and Bio-based Chemical Technology, Korea Research Institute of Chemical Technology, Ulsan, Republic of Korea

    1 shared publication
  • Ji-Eun Jeong

    Center for Specialty Chemicals, Division of Specialty and Bio-based Chemical Technology, Korea Research Institute of Chemical Technology, Ulsan, Republic of Korea

    1 shared publication
  • Jihee Won

    Coulter Department of Biomedical Engineering, Georgia Institute of Technology & Emory University School of Medicine, Atlanta, USA

    1 shared publication
  • Jin Chul Kim

    Center for Specialty Chemicals, Division of Specialty and Bio-based Chemical Technology, Korea Research Institute of Chemical Technology, Ulsan, Republic of Korea

    1 shared publication
  • Min-Kyu Kang

    School of Nanomedical Engineering, Korea National University of Transportation, Chungju-si 27469, Republic of Korea

    1 shared publication

Latest Publications

  • Open Access

    Polymeric Biomaterials for the Delivery of Stem Cell-Derived Exosomes in Inflammatory Skin Diseases: Engineering Strategies and Synergistic Effects

    by Myungkyung Noh, Tae-Hyun Heo, Min-Kyu Kang, Gun-Jae Jeong

    Skin tissue engineering has emerged as a promising therapeutic strategy for severe wounds and inflammatory skin diseases. Stem cell-derived exosomes (SC-Exos) have recently gained increasing attention as cell-free therapeutic agents with regenerative and immunomodulatory potential, offering possible advantages over direct stem cell transplantation. To fully realize their therapeutic potential, however, efficient delivery platforms are needed to enhance local retention, preserve vesicle integrity, and support sustained release within the diseased skin microenvironment. In this review, we discuss advanced polymeric biomaterials as functional delivery platforms for SC-Exos in skin tissue engineering. We focus on natural and synthetic polymers engineered into nanofibrous scaffolds, hydrogels, and microneedles, and examine how these systems enhance exosome loading, protect vesicle integrity, improve local retention, and modulate release kinetics. We further highlight the therapeutic effects and underlying mechanisms of polymer–exosome systems in skin lesion repair, focusing on their roles in promoting angiogenesis, modulating local inflammation and immune responses, and facilitating extracellular matrix remodeling. Finally, we address remaining challenges and future directions for translating polymer-based SC-Exos delivery platforms into clinically relevant skin regenerative therapies.


  • Open Access

    Divergent mitochondrial and fibrotic signatures in atrial fibrillation: insights from organoids and GEO data

    by Jihee Won, Hyocheol Jung, Jin Chul Kim, Ji-Eun Jeong, Young Il Park, Biaggio Uricoli, Sanghee Lee, Young Hoon Son, Gun-Jae Jeong

    Background: Atrial fibrillation (AF) remains a major clinical burden because structural and metabolic remodeling, particularly mitochondrial dysfunction and fibrosis, often persists beyond rhythm control. Human-relevant models that disentangle these axes and connect them to patient data are limited. Methods: Human atrial organoids were exposed to two AF-relevant stressors: rapid pacing (FP) and angiotensin II (AngII). We assessed mitochondrial and fibrotic remodeling by transcript/protein analyses, imaging, and contractility readouts, and benchmarked organoid responses against four public AF transcriptomic datasets (GEO: GSE128188, GSE138252, GSE222793, GSE239321). Statistical analyses used predefined contrasts versus matched controls with multiple-testing correction. Results: FP predominantly suppressed mitochondrial biogenesis/oxidative programs and increased stress-response features, resembling signatures observed in AF with heart failure (e.g., downregulation of mitochondrial regulators and altered cytochrome c patterns). AngII elicited stronger profibrotic signaling with a mixed mitochondrial response, mirroring profiles more typical of AF without heart failure. Both stressors impaired organoid contractility. Protein and immunostaining corroborated mitochondria–fibrosis crosstalk, with changes in PGC1α and cytochrome c alongside increased extracellular matrix deposition and myofibroblast markers (COL1A1, αSMA), consistent with stimulus-specific but partially overlapping remodeling trajectories. Conclusion: Distinct AF-relevant stressors drive divergent mitochondrial and fibrotic remodeling in human atrial organoids that recapitulate key features of patient datasets. These organoid models provide a translational platform to prioritize mitochondria-targeted and antifibrotic interventions and to inform biomarker development for residual dysfunction in AF.